Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CFSAN Bioterrorism Regs Should Include Grandfather Clause – CHPA

This article was originally published in The Tan Sheet

Executive Summary

FDA should grandfather any food ingredient or product already in the chain of distribution when it implements provisions in the Public Health Security & Bioterrorism Preparedness & Response Act, according to CHPA

You may also be interested in...



Electronic Facility Registration Encouraged In FDA Bioterrorism Reg

Food facilities that operate on a seasonal basis may include the dates they are open for business when registering with FDA

Electronic Facility Registration Encouraged In FDA Bioterrorism Reg

Food facilities that operate on a seasonal basis may include the dates they are open for business when registering with FDA

Electronic Facility Registration Encouraged In FDA Bioterrorism Reg

Food facilities that operate on a seasonal basis may include the dates they are open for business when registering with FDA

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094495

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel